Frontiers in nutrition · 2026
Gut microbiota mediates the anti-obesity effects of Gnaphalium affine methanol extract in HFD-induced obesity.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Yu Zhihao, Ma Huaizhi, Zhang Huiyuan, Gao Linlin, Fu Xinrui, Wang Haoyu, Xiao Yao, Wu Xiaojuan, Zhang Andong, Kang Yingqian, Cui Guzhen, Chen Zhenghong, Wu Daoyan
Аннотация
BACKGROUND: Obesity constitutes a pressing global public health challenge, characterized by intricate associations with metabolic dysregulation and gut microbiota dysbiosis.
METHODS: This study systematically evaluated the anti-obesity efficacy and underlying mechanisms of Gnaphalium affine methanol extract (GAE) in high-fat diet (HFD)-induced obese mice, with integrated fecal microbiota transplantation (FMT) experiments to establish causal relationships between GAE-modulated gut microbiota and metabolic improvements.
RESULTS: GAE intervention significantly ameliorated HFD-induced metabolic disorders, as evidenced by reduced oxidative stress, enhanced glucose tolerance, suppressed visceral adiposity, and attenuated chronic low-grade inflammation. Mechanistically, GAE preserved intestinal barrier integrity through upregulation of tight junction protein expression. Multi-omics integration of 16S rRNA gene sequencing and untargeted metabolomics revealed that GAE substantially rectified gut microbiota dysbiosis and lipid metabolic disturbances, mediated by specific bioactive metabolites-including lysophosphatidylcholine 22:6 and N-oleoyl glycine-and enrichment of beneficial bacterial genera (Phascolarctobacterium and Lactobacillus). Critically, FMT experiments demonstrated that the gut microbiota remodeled by GAE administration was sufficient to transfer obesity-alleviating phenotypes to recipient mice.
CONCLUSION: Collectively, these findings establish that GAE exerts multi-target anti-obesity effects through modulation of the "microbiota-gut-metabolism" axis, providing compelling preclinical evidence supporting the development of GAE as a functional food ingredient for weight management applications.
METHODS: This study systematically evaluated the anti-obesity efficacy and underlying mechanisms of Gnaphalium affine methanol extract (GAE) in high-fat diet (HFD)-induced obese mice, with integrated fecal microbiota transplantation (FMT) experiments to establish causal relationships between GAE-modulated gut microbiota and metabolic improvements.
RESULTS: GAE intervention significantly ameliorated HFD-induced metabolic disorders, as evidenced by reduced oxidative stress, enhanced glucose tolerance, suppressed visceral adiposity, and attenuated chronic low-grade inflammation. Mechanistically, GAE preserved intestinal barrier integrity through upregulation of tight junction protein expression. Multi-omics integration of 16S rRNA gene sequencing and untargeted metabolomics revealed that GAE substantially rectified gut microbiota dysbiosis and lipid metabolic disturbances, mediated by specific bioactive metabolites-including lysophosphatidylcholine 22:6 and N-oleoyl glycine-and enrichment of beneficial bacterial genera (Phascolarctobacterium and Lactobacillus). Critically, FMT experiments demonstrated that the gut microbiota remodeled by GAE administration was sufficient to transfer obesity-alleviating phenotypes to recipient mice.
CONCLUSION: Collectively, these findings establish that GAE exerts multi-target anti-obesity effects through modulation of the "microbiota-gut-metabolism" axis, providing compelling preclinical evidence supporting the development of GAE as a functional food ingredient for weight management applications.